- Investing Ideas
- /
- German Pharmaceuticals & Biotech Strong Balance Sheet Stocks
German Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
15
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
15 companies
2invest
Market Cap: €67.3m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.
2INV
€12.20
7D
-3.2%
1Y
40.2%
Merck KGaA
Market Cap: €50.2b
Operates as a science and technology company in Germany.
MRK
€115.35
7D
-2.0%
1Y
-31.5%
Cantourage Group
Market Cap: €80.3m
Operates as a medical cannabis company in Europe.
HIGH
€6.44
7D
11.0%
1Y
-10.6%
Apontis Pharma
Market Cap: €96.6m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€11.60
7D
2.7%
1Y
41.8%
SCHOTT Pharma KGaA
Market Cap: €4.2b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
1SXP
€28.10
7D
-5.9%
1Y
-1.5%
Liminal BioSciences
Market Cap: €11.8m
Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.
PJ2
€3.80
7D
0%
1Y
-0.7%
4SC
Market Cap: €14.4m
A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany.
VSC
€1.32
7D
-26.7%
1Y
-82.4%
Evotec
Market Cap: €1.2b
Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
EVT
€7.02
7D
-1.3%
1Y
-17.4%
Formycon
Market Cap: €399.9m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.65
7D
-0.7%
1Y
-46.8%
Biofrontera
Market Cap: €15.1m
A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.
B8FK
€2.49
7D
-5.7%
1Y
-31.5%
Darwin
Market Cap: €89.4m
Operates as a biotechnology company.
7V0
€29.80
7D
0%
1Y
-17.7%
bioXXmed
Market Cap: €211.7k
An investment company, invests in biotechnology or medical technology companies with equity or debt capital.
T5O0
€0.41
7D
0%
1Y
-92.4%
Heidelberg Pharma
Market Cap: €160.8m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.
HPHA
€3.45
7D
5.5%
1Y
18.2%
MPH Health Care
Market Cap: €111.7m
An investment company, engages in the healthcare business in Germany.
93M1
€25.40
7D
0.8%
1Y
-19.1%
Medigene
Market Cap: €1.3m
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.08
7D
-28.4%
1Y
-96.7%